Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
Clinical trial NCT01453023 · COMPLETED
Trial details
- NCT number
- NCT01453023
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2012-06-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.